Nerve injury pain remains a complex clinical challenge. Although the develo
pment of animal models of nerve injury pain has aided our understanding of
potential pathophysiologic mechanisms for this condition, effective treatme
nt still remains beyond our reach. Several classes of agents appear to bloc
k pain behavior in these animal models and humans, but they are often limit
ed in their: use by low efficacy, or undesirable side-effects. A prerequisi
te for the improvement of nerve injury pain includes the development of cli
nically-relevant animal models in which therapeutic targets can be identifi
ed.